Clinical characteristics of ocular toxocariasis in Eastern China.

Authors: Zhou M,Chang Q,Gonzales JA,Chen Q,Zhang Y,Huang X,Xu G,Wang W,Jiang R,
Address: Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, 83 Fenyang Rd, Shanghai, China.
Journal: Graefes Arch Clin Exp Ophthalmol.


Publication: 2012 Sep;250(9):1373-8. doi: 10.1007/s00417-012-1971-2. Epub 2012 Feb 28.

abstract

PURPOSE:

To explore the Clinical characteristics of patients with ocular toxocariasis in Eastern China.

METHODS:

The medical records of 35 cases of ocular toxocariasis in Fudan University Eye & ENT Hospital between May 2009 and April 2011 were retrospectively reviewed and analyzed. UBM, RetCam or fundus imaging, and high-frequency or conventional ultrasonography were performed in these patients.

RESULTS:

The mean patient age in our series of ocular toxocariasis was 11.86 ± 8.80 years. There were 28 children and seven adults, the majority residing in a rural area (88.57%). All cases were classified into three clinical subtypes: granuloma in the peripheral retina (60% of cases); granuloma in the posterior pole (28.57% of cases); and vitreous inflammation mimicking chronic endophthalmitis (5.71% of cases). We also identified an additional subtype with unique clinical features that we termed "combined type" presenting in 5.71% of our patients. This subtype exhibited granulomas in both the posterior pole and peripheral retina. RetCam fundus imaging was able to identify granulomas in the posterior and peripheral subtypes, 100% and 80.95% of cases respectively. Moreover, UBM combined with conventional ultrasonography identified granulomas in 95% of the peripheral subtype cases and in 100% of the posterior pole subtype cases.

CONCLUSIONS:

This is the first ocular toxocariasis series described in Chinese patients. Compared with reports from developed countries, the ocular features in our series were more severe and complicated, presenting with poorer visual acuity and a high rate of retinal detachment (45.7%). The application of RetCam and UBM during examination in ocular toxocariasis can provide valuable information in determining the severity of disease and features important in considering surgical procedures in such patients.



Related Articles
Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis.
Retina. 2005
Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis.
Stewart JM, Cubillan LD, Cunningham ET Jr. Retina. 2005 Dec; 25(8):1005-13.
[Ultrasonographic findings in ocular toxocariasis].
Arq Bras Oftalmol. 2012
[Ultrasonographic findings in ocular toxocariasis].
Morais FB, Maciel AL, Arantes TE, Muccioli C, Allemann N. Arq Bras Oftalmol. 2012 Jan-Feb; 75(1):43-7.
[Clinical features, the effectiveness of treatment and function of vision organ in children and adolescents with ocular toxocariasis].
Klin Oczna. 2008
[Clinical features, the effectiveness of treatment and function of vision organ in children and adolescents with ocular toxocariasis].
Urban B, Bakunowicz-Łazarczyk A, Michał S. Klin Oczna. 2008; 110(10-12):364-6.
Review Nematode infections of the eye: toxocariasis and diffuse unilateral subacute neuroretinitis.
Curr Opin Ophthalmol. 2001
Review Nematode infections of the eye: toxocariasis and diffuse unilateral subacute neuroretinitis.
Sabrosa NA, de Souza EC. Curr Opin Ophthalmol. 2001 Dec; 12(6):450-4.
Review The epidemiology of ocular toxocariasis.
J Helminthol. 2001
Review The epidemiology of ocular toxocariasis.
Taylor MR. J Helminthol. 2001 Jun; 75(2):109-18.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.